ABC Money
Home

Pharmion, Methylgene report favourable results for Phase 2 MGCD0103 trial


Published : Mon, 10 Dec 2007 07:16
By : Agencies
Print this Story

AddThis Social Bookmark Button

ATLANTA (Thomson Financial) - Pharmion Corp and MethylGene Inc said two ongoing Phase 2 studies with their novel MGCD0103 as a single-agent in the treatment of Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL) had shown favourable results.

'These exploratory Phase 2 trials show meaningful activity of MGCD0103 in patients with differing types of lymphomas,' said Patrick J Mahaffy, president and chief executive officer of Pharmion.

Donald F Corcoran, president and chief executive officer of MethylGene, said the companies will continue to evaluate the current and near-term MGCD0103 clinical trials during 2008 with the goal to develop a potential registrational pathway.

tf.TFN-Europe_newsdesk@thomson.com

ak/ak

COPYRIGHT

Copyright Thomson Financial News Limited 2007. All rights reserved.

The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.

Share on


 You Might Like
GPC says satraplatin fails to improve survival versus placebo
UPDATE: Prostate cancer drug trial's failure hits Spectrum Pharma, GPC shares
+
BioXell to commence phase IIa trial on Elocalcitol's effects on male infertility

Comment on this Article
Comment:
Title:
Name:
Please Enter
 
Here
  

 Search News

 Look For
Business
Credit cards
Finance
Loans
Money
Mortgages

 
 Stock Quotes *
SYMBOL
LAST
CHANGE
DOW JONES
8663.45
-79.01 ( -0.90 %)
NASDAQ
1584.91
-32.10 ( -1.99 %)
FTSE 100
4448.54
-56.83 ( -1.26 %)

SYMBOL ( 2009-01-09 )
LAST
CHANGE
BRITISH AMERICAN TOBACCO ( 11:35am )
1852.00
+66.00 ( 3.67 %)
NORTHERN ROCK ( 11:35am )
182.00
+19.04 ( 11.20 %)
INTERCONTINENTAL HOTEL GROUP ( 11:35am )
613.50
+17.50 ( 2.90 %)
ASTRAZENECA ( 11:35am )
2744.00
+12.00 ( 0.44 %)
CARNIVAL ( 11:35am )
1519.00
+12.00 ( 0.79 %)

SYMBOL ( 2009-01-09 )
LAST
CHANGE
WAL MART STORES ( 3:16pm )
51.77
+0.39 ( 0.76 %)
ALTRIA GROUP INC ( 3:16pm )
15.47
+0.37 ( 2.43 %)
JOHNSON & JOHNSON ( 3:16pm )
59.23
+0.21 ( 0.36 %)
GENERAL MOTORS ( 3:16pm )
4.09
+0.05 ( 1.23 %)
HEWLETT PACKARD CO ( 3:16pm )
37.62
-0.02 ( -0.05 %)

SYMBOL ( 2009-01-09 )
LAST
CHANGE
STRAYER EDUCATION ( 3:12pm )
215.57
+20.94 ( 10.01 %)
APOLLO GP INC A ( 3:26pm )
85.87
+8.65 ( 9.97 %)
FIRST SOLAR INC ( 2:57pm )
163.92
+8.56 ( 5.37 %)
ISRAMCO INC ( 1:42pm )
31.25
+4.39 ( 14.49 %)
LIBERTY GLOBAL CL-B ( 3:36pm )
19.23
+3.41 ( 17.95 %)

Gainers & Losers
Dow Jones
Euro Stoxx 50
FTSE 100
FTSE 250
FTSE AIM
FTSE ALL
Nasdaq

 Portfolio Manager

You must log in to access this area of the site. If you are not a registered user click here to sign up for instant access!

 Finance Explained

Money making ideas

Save money
Money management
Savings accounts
Investing money
Share dealing
Stock broker
Forex currency trading
Pension plans
Functions of Money

(c) 2007 ABCmoney.co.uk, All Rights Reserved
*ABCMoney.co.uk does not guarantee the accuracy of any share prices or stock quotations displayed. These are not real time quotes; all are delayed by at least twenty minutes and are for information purposes only.